Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NRIX

Nurix Therapeutics Inc

22.90

Jun 26 • 04:00PM ET +0.44 (1.96%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR RCUS TNGX CGON NUVL RYTM BMRN INCY KRYS AXSM

| Held by: VTI XBI IWM ARKG IWN VXF IBB SCHA VTWO DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.16	Insider Own	5.34%	Shs Outstand	103.40M	Perf Week	30.48%
Market Cap	2.37B	Forward P/E	-	EPS next Y	-2.39	Insider Trans	-2.23%	Shs Float	97.92M	Perf Month	31.08%
Enterprise Value	1.89B	PEG	-	EPS next Q	-0.72	Inst Own	108.39%	Short Float	20.45%	Perf Quarter	47.46%
Income	-295.28M	P/S	32.99	EPS this Y	17.94%	Inst Trans	2.51%	Short Ratio	10.82	Perf Half Y	18.71%
Sales	71.78M	P/B	4.92	EPS next Y	4.57%	ROA	-47.20%	Short Interest	20.02M	Perf YTD	20.72%
Book/sh	4.65	P/C	4.38	EPS next 5Y	20.61%	ROE	-61.40%	52W High	23.09 -0.82%	Perf Year	93.41%
Cash/sh	5.23	P/FCF	-	EPS past 3/5Y	6.31% -2.04%	ROIC	-55.05%	52W Low	8.19 179.44%	Perf 3Y	138.05%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	29.55% 36.35%	Gross Margin	74.22%	Volatility	8.72% 8.06%	Perf 5Y	-22.40%
Dividend TTM	-	EV/Sales	26.27	EPS Y/Y TTM	-12.53%	Oper. Margin	-439.26%	ATR (14)	1.39	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.01	Sales Y/Y TTM	27.23%	Profit Margin	-411.37%	RSI (14)	82.12	Recom	1.19
Dividend Gr. 3/5Y	- -	Current Ratio	6.01	EPS Q/Q	-17.44%	SMA20	31.47%	Beta	1.76	Target Price	31.44
Payout	-	Debt/Eq	0.12	Sales Q/Q	-66.12%	SMA50	35.05%	Rel Volume	3.24	Prev Close	22.46
Employees	317	LT Debt/Eq	0.12	Earnings	Apr 08 BMO	SMA200	49.17%	Avg Volume	1.85M	Price	22.90
IPO	Jul 24, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.59% -56.13%	Trades		Volume	5,987,389	Change	1.96%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)